Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Pregnancy Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Spondylarthritis 1 Papillomavirus Infections 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 47 Etoposide 27 Irinotecan 25 Temozolomide 24 Melphalan 24 3-Iodobenzylguanidine 22 Topotecan 20 Filgrastim 20 Isotretinoin 19 Carboplatin 18 Granulocyte Colony-Stimulating Factor 16 sargramostim 15 fludarabine 15 Granulocyte-Macrophage Colony-Stimulating Factor 15 humanized 3F8 anti-GD2 monoclonal antibody 14 dinutuximab 13 Peripheral Blood Stem Cell Transplantation 13 Doxorubicin 13 Cisplatin 13 Radiotherapy 12 Interleukin-2 12 Busulfan 12 naxitamab 11 Vincristine 11 fludarabine phosphate 10 aldesleukin 9 Thiotepa 9 Eflornithine 8 Vorinostat 7 Stem Cell Transplantation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡